九源基因(02566)上涨5.13%,报7.79元/股

金融界
11 Dec 2024

12月11日,九源基因(02566)盘中上涨5.13%,截至14:10,报7.79元/股,成交377.99万元。

杭州九源基因工程股份有限公司主营业务为生物药品及医疗器械的研发、生产和商业化,专注于骨科、代谢疾病、肿瘤及血液四大治疗领域。根据相关资料,这四个领域预计在不久的将来将持续占据中国药物总销售额的51.5%,大大超过中国医药行业的整体表现。

截至2024年中报,九源基因营业总收入7.02亿元、净利润1.05亿元。

责任编辑:磐石

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10